Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Galvusmet 50/850mg°°


Contraindicated

Contraindicated
Galvusmet 50/850mg°° :
Type Medicine Withdrawn
Originator B
Agent Khalil Fattal & Fils
Distributor Khalil Fattal & Fils
Laboratory Novartis
Responsible Party Novartis Pharma AG
Origin Switzerland
Manufacturer Novartis Pharma Produktions GmbH
Origin Germany
ATC A10BD08

Your comment will appear shortly after approval

Galvusmet 50/850mg°° :

Revision Date : 21/05/2015


Effect Frequency
Abdominal pain Very Common
ALT increased Not known
Angioedema (Angioneurotic oedema) (Quincke oedema) Not known
Arthralgia (Pain joint) (Joint ache) Uncommon
AST increased Not known
Asthenia Common
Blood glucose decreased Common
Chills Common
Constipation Uncommon
Decreased appetite Very Common
Dermatitis bullous Not known
Diarrhoea (Diarrhea) Very Common
Dizziness Common
Dysguesia (taste perversion) (Taste abnormality) (Taste disturbance) Common
Erythema Very rare
Fatigue Uncommon
Flatulence Uncommon
Gastrooesophageal reflux disease Common
Headache Common
Hepatic function abnormal Not known
Hepatitis Not known
Hyperhidrosis Common
Hypoglycaemia Common
Lactic acidosis Very rare
Liver function test abnormal Not known
Myalgia Not known
Nasopharyngitis Very rare
Nausea Very Common
Oedema peripheral Uncommon
Pancreatitis Not known
Pruritus Very rare
Skin exfoliation (Flaking skin) Not known
Skin reaction Very rare
Tremor Common
Upper respiratory tract infection Very rare
Urticaria Very rare
Vitamin B12 deficiency Very rare

Different Units By MoH Code

Revision Date : 30/09/2010

Galvusmet 50/850mg°°  MoH 7833 :
Form Tablet, Film-Coated
Packaging Blisters
Package Size Box of 60
Strength 50mg/850mg
Stratum N/A
NSSF ✘
Quarantine ✘
Reg. Number 90614/1
Submission date 01/01/2014
Registration Year 2014
Withdrawn Date 01/03/2022


Price Comparison

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info